<DOC>
	<DOCNO>NCT02061527</DOCNO>
	<brief_summary>To evaluate breast reconstruction implant use biological mesh ( Strattice™ ) set breast cancer treatment .</brief_summary>
	<brief_title>Breast Reconstruction With Acellular Dermal Matrix Setting Breast Cancer Treatment</brief_title>
	<detailed_description>OBJECTIVES : To evaluate outcome immediate breast reconstruction Acellular Dermal Matrix ( Strattice™ ) , measure safety , effectiveness , cost . The primary outcome measure number unplanned surgical procedure . STUDY DESIGN : A prospective randomize multicenter trial . One hundred twenty patient breast cancer enrol study . Study duration two year time primary cancer surgery . TRIAL DESIGN This randomize control multicenter trial , compare IBR without ( group A ) ( group B ) use ADM . Participants eligible study patient breast cancer , plan mastectomy , wish IBR implant . Each participant individually randomize either reconstruct use implant total submuscular coverage ( A ) reconstruction ADM partial muscle coverage ( B ) . Method assign patient treatment group : After sign date informed consent patient enter study . If inclusion none exclusion criterion full fill , patient randomize group A group B. TREATMENT/ INTERVENTION The decision treatment plan advocate mastectomy base multi disciplinary conference ( MDT ) , diagnosis invasive pre-invasive ( situ ) breast cancer make triple assessment . If patient wish undergo immediate implant base reconstruction , meet selection criterion enter study , randomly select treated accord Group A Group B . Group A reconstruct expander anatomical gel implant without ADM , use complete muscle coverage . Group B reconstruct expander anatomical gel implant use partial muscle coverage conjunction ADM. Randomization enrollment make regard use ADM , expander direct-to-implant technique utilized group , depend quality skin flap time surgery . RANDOMIZATION TYPE Patients allocate treatment accord permuted block technique . The actual randomization perform use computer base system locate Regional Cancer Center ( RCC ) within Karolinska Institutet . In system inclusion exclusion criterion automatically check patient randomize treatment . The randomization process stratify participate unit . STATISTICAL METHODS The main endpoint analyze proportion unplanned reoperations initial breast reconstruction . The difference proportion two group present difference proportion together 95 % confidence interval . Differences test use Fishers Exact Test . Logistic regression use take account possible confounding factor . STUDY MANAGEMENT Data recording : The investigator ensure data patient visit enter promptly ink , case report form ( CRF ) . The principal investigator must sign final CRF page attest accuracy completeness data . The data CRFs transfer database . Monitoring audit : At period exceed 3 month , center contact discuss progress trial , purpose verify CRF data source record accuracy data record collection .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Patient invasive preinvasive ( situ ) breast cancer , plan immediate breast reconstruction postskin spar nipple spar mastectomy ( unilateral bilateral ) Patient agree participate study sign inform consent form Able willing return schedule require study visit Is smoker ( patient quit least 4 week prior surgery include ) BMI &lt; 18 &gt; 30 Previous radiation therapy region time Insulindependent diabetes immune deficiency require immunosuppressant use cortisone biological therapy Predicted implant size &lt; 200 &gt; 600 ml per investigator assessment Allergy porcine Pregnancy lactate Current enrollment plan enroll another clinical trial unless retrospective study Neoadjuvant treatment chemotherapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>ADM</keyword>
	<keyword>Strattice</keyword>
	<keyword>Breast reconstruction</keyword>
	<keyword>Immediate breast reconstruction</keyword>
	<keyword>IBR</keyword>
	<keyword>Acellular dermal matrix</keyword>
	<keyword>Biological mesh</keyword>
	<keyword>Randomized control trial</keyword>
	<keyword>RCT</keyword>
	<keyword>Breast cancer</keyword>
	<keyword>Implants</keyword>
	<keyword>Mastectomy</keyword>
	<keyword>Direct-to-implant</keyword>
</DOC>